Open Access Peer-Reviewed
Artigo Original

Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab

Avaliação da sensibilidade ao contraste em retinopatia diabética proliferativa de não alto risco tratada com panfotocoagulação retiniana com ou sem injeções intravítrea de ranibizumabe

Zubir S. RentiyaΔ1; Daniel A. FerrazΔ1,2,3,4; Robert Hutnik5; Junun Bae1,6; Cleide G. Machado2; Cristina Mucciolli3; Augusto Alves L. da Motta2; Lucas Z. Ribeiro3; Zeyu Guan4; Rony Carlos Preti2; Walter Y. Takahashi2

DOI: 10.5935/0004-2749.20220006

1. Johns Hopkins University School of Medicine, Department of Radiology, Neurology, Ophthalmology, Baltimore, MD, USA
2. Division of Ophthalmology, University of São Paulo, São Paulo, SP, Brazil
3. Division of Ophthalmology, Federal University of São Paulo, São Paulo, SP,Brazil
4. Moorfield’s Eye Hospital, London, UK
5. Stony Brook Medicine, Department of Surgery, Stony Brook, NY, USA
6. Lake Erie College of Osteopathic Medicine, Erie, PA, USA

Corresponding author

Daniel A. Ferraz
E-mail: danielferraz1@hotmail.com


Dimension

© 2022 - All rights reserved - Conselho Brasileiro de Oftalmologia